Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. [Dado Ruvic, Illustration, Reuters]Johnson & Johnson’s one-shot Covid-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration (FDA) staff said in documents published on Wednesday, paving the way for its approval for emergency use. While it is not bound to follow the advice of its experts, the FDA did so when authorizing the Pfizer Inc and Moderna Inc vaccines. J&J’s vaccine was 66 per cent effective in preventing COVID-19 against multiple variants in a global trial involving nearly 44,000 people, the company said last month. The vaccine was effective in reducing the risk of Covid-19 and preventing PCR-test confirmed Covid-19 at least 14 days after vaccination, the FDA said in its briefing documents.

Source: Standard Digital February 24, 2021 14:31 UTC